During the past decade, The First Affiliated Hospital of Kunming Medical University conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 8 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 7 clinical trials were completed. i.e. 70% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The First Affiliated Hospital of Kunming Medical University" #1 sponsor was "Hoffmann-La Roche" with 5 trials, followed by "Takeda" with 4 trials sponsored, "Chia Tai Tianqing Pharmaceutical Group Co., Ltd." with 3 trials sponsored, "Shanghai Mental Health Center" with 3 trials sponsored and "Eli Lilly and Company" with 3 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The First Affiliated Hospital of Kunming Medical University" #1 collaborator was "First Affiliated Hospital of Kunming Medical University" with 4 trials as a collaborator, "The First Affiliated Hospital of Zhengzhou University" with 3 trials as a collaborator, "The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School" with 2 trials as a collaborator, "Affiliated Hospital of Nantong University" with 1 trials as a collaborator and "Amylin Pharmaceuticals, LLC." with 1 trials as a collaborator. Other collaborators include 74 different institutions and companies that were collaborators in the rest 84 trials.

According to Clinical.Site data, the most researched conditions in "The First Affiliated Hospital of Kunming Medical University" are "Depression" (2 trials), "Erosive Esophagitis" (2 trials), "Hepatitis B, Chronic" (2 trials), "Medullary Thyroid Carcinoma" (2 trials) and "Ulcerative Colitis" (2 trials). Many other conditions were trialed in "The First Affiliated Hospital of Kunming Medical University" in a lesser frequency.

Most popular intervention types in "The First Affiliated Hospital of Kunming Medical University" are "Drug" (25 trials), "Device" (3 trials), "Other" (3 trials), "Procedure" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Lansoprazole" (4 trials), "Lansoprazole Placebo" (4 trials), "Anlotinib" (2 trials) and "Bismuth-Containing Quadruple Therapy" (2 trials). Other intervention names were less common.

The vast majority of trials in "The First Affiliated Hospital of Kunming Medical University" are 34 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "The First Affiliated Hospital of Kunming Medical University". 2 are not yet recruiting, 8 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in The First Affiliated Hospital of Kunming Medical University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in The First Affiliated Hospital of Kunming Medical University, 1 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 5 trials that are defined as “Not Applicable".